Total raised
—
Stage
—
Founded
2003
Headcount
44
HQ
France
Sector
—
About
SEQENS is a global leader in pharmaceutical solutions and specialty ingredients. They provide a range of products, including generic and custom APIs, intermediates, and excipients for pharmaceuticals, along with ingredients for personal care and specialty chemicals. With 16 production sites and 9 R&D centers across 9 countries, SEQENS serves over 1,500 customers in more than 80 countries.
In 2021, Private equity group SK Capital Partners has completed the acquisition of a majority stake in French firm Seqens, at the same time merging portfolio company Wavelength Pharmaceuticals into Seqens.